Health Sciences Group Inc (HESG)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0020 +0.0019 (+1900.00%) 02/29/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0020 unch (unch) 15:42 ET
for Thu, Feb 29th, 2024
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2017 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
Cash Flows From Operating Activities | |||||
Net Income | N/A | N/A | -5,750 | -10,440 | -7,410 |
Depreciation Amortization | N/A | N/A | 2,510 | 1,590 | 1,470 |
Other Working Capital | N/A | N/A | -4,260 | 4,720 | 730 |
Other Operating Activity | 0 | 0 | 3,770 | 2,580 | 4,070 |
Operating Cash Flow | $N/A | $N/A | $-3,730 | $-1,550 | $-1,140 |
Cash Flows From Investing Activities | |||||
PPE Investments | N/A | N/A | 0 | -3 | -90 |
Net Acquisitions | N/A | N/A | 200 | 210 | -240 |
Other Investing Activity | 0 | 0 | -360 | 3 | 0 |
Investing Cash Flow | $N/A | $N/A | $-160 | $210 | $-330 |
Cash Flows From Financing Activities | |||||
Other Financing Activity | 0 | 0 | 3,680 | 1,460 | 1,570 |
Financing Cash Flow | $N/A | $N/A | $3,680 | $1,460 | $1,570 |
Beginning Cash Position | N/A | N/A | 240 | 120 | 160 |
End Cash Position | N/A | N/A | 20 | 240 | 260 |
Net Cash Flow | $N/A | $N/A | $-210 | $110 | $90 |
Free Cash Flow | |||||
Operating Cash Flow | N/A | N/A | -3,730 | -1,550 | -1,140 |
Free Cash Flow | 0 | 0 | -3,730 | -1,550 | -1,140 |